Chemical inhibition of de novo fatty acid synthesis decreases the proliferation of cultured breast cancer cells, reduces activation of signaling pathways, and in some cases, slows the growth of xenograft tumors [10],[48],[51]-[53]; and direct inhibition of FASN has been explored for cancer therapy [48],[53]-[57]. The gene discussed is FASN; the disease is cancer.